Search results
Results from the WOW.Com Content Network
Glioblastoma, formerly known as glioblastoma multiforme, is a devastating type of cancer that can result in death in fewer than six months without treatment. It’s important to seek diagnosis and treatment as soon as possible to prolong your life.
Glioblastoma treatment options include: Surgery to remove the glioblastoma. A brain surgeon, also known as a neurosurgeon, works to remove as much of the cancer as possible. Glioblastoma often grows into the healthy brain tissue, so it might not be possible to remove all of the cancer cells.
There is currently no cure for glioblastoma. The median length of survival after a diagnosis is 15-18 months, while the disease’s five-year survival rate is around 10%. Though all glioblastomas recur, initial treatments may keep the tumor controlled for months or even years.
Glioblastoma is an aggressive brain tumor, also known as glioblastoma multiforme. It is life threatening and has a median survival time of only 15 months. However, it is also rare.
Glioblastoma — Overview covers diagnosis and treatment for this aggressive form of brain cancer that can be slowed, but often can't be cured.
What's the treatment for GBM? The standard of treatment for a GBM is surgery, followed by daily radiation and oral chemotherapy for six and a half weeks, then a six-month regimen of oral chemotherapy given five days a month.
Tumor treating fields therapy is used to treat an aggressive type of glioma called glioblastoma. This treatment is often done at the same time as chemotherapy. During this treatment, sticky pads are attached to the scalp.
Regardless of ideal multidisciplinary treatment, including maximal surgical resection, followed by radiotherapy plus concomitant and maintenance temozolomide (TMZ), almost all patients experience tumor progression with nearly universal mortality and a median survival of less than 15 months.
In a major advance for the treatment of the deadly brain cancer glioblastoma, Northwestern Medicine scientists used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy and immunotherapy drug cocktail.
Brain tumor clinical trials provide glioblastoma patients with innovative treatment options when standard care proves ineffective and may be recommended as a first-line option in some instances. Clinical trials test new drugs, interventions and diagnostic tools that the FDA has yet to approve and offer patients access to cutting-edge therapies ...